Overall, these observations uncover a novel interplay of melanoma cell-intrinsic STING and IFN/JAK signaling pathways that will be important to consider for future therapeutic strategies that seek to inhibit melanoma progression and immunotherapy resistance associated with paracrine Activin-A signaling. The gene discussed is STING1; the disease is melanoma.